Cargando…

Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ symptoms and HRQOL in a well-documented clinical cohort during their last two years o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajala, K., Lehto, J. T., Sutinen, E., Kautiainen, H., Myllärniemi, M., Saarto, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247520/ https://www.ncbi.nlm.nih.gov/pubmed/30458739 http://dx.doi.org/10.1186/s12890-018-0738-x

Ejemplares similares

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

End-of-life care of patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2016)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

Clinical Profile of Patients with Idiopathic Pulmonary Fibrosis in Real Life
por: Morena, Diego, et al.
Publicado: (2023)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis
por: Olson, Amy L, et al.
Publicado: (2016)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
por: Harari, Sergio, et al.
Publicado: (2015)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
por: Akiyama, Norimichi, et al.
Publicado: (2022)

Palliative care and end of life management in patients with idiopathic pulmonary fibrosis
por: Micco, Assunta, et al.
Publicado: (2023)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
por: Kreuter, Michael, et al.
Publicado: (2017)

Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis
por: Machado, Felipe V C, et al.
Publicado: (2021)

Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Cox, Ingrid A., et al.
Publicado: (2020)

Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
por: Jia, Minxue, et al.
Publicado: (2023)

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
por: Vietri, Lucia, et al.
Publicado: (2020)

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
por: Partanen, Juulia J., et al.
Publicado: (2022)

The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study
por: Wapenaar, Monique, et al.
Publicado: (2020)

The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review
por: Zou, Richard H., et al.
Publicado: (2020)

A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial Pneumonia
por: Kirsten, Detlef, et al.
Publicado: (2021)

Quality of care in the last year of life: adaptation and validation of the German “Views of Informal Carers’ Evaluation of Services – Last Year of Life – Cologne”
por: Dust, Gloria, et al.
Publicado: (2022)

The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study
por: Janssen, Katherine, et al.
Publicado: (2020)

The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study
por: Sokai, Akihiko, et al.
Publicado: (2017)

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
por: Wuyts, Wim A., et al.
Publicado: (2022)

The effect of preoperative stoma site marking on quality of life
por: Cakir, Selda Karaveli, et al.
Publicado: (2018)

Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
por: Krafft, E., et al.
Publicado: (2014)

Effect of Chest Physiotherapy on Quality of Life, Exercise Capacity and Pulmonary Function in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Martín-Núñez, Javier, et al.
Publicado: (2023)

Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)
por: Yorke, Janelle, et al.
Publicado: (2014)

Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study
por: Magnani, Daniela, et al.
Publicado: (2017)

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease
por: Pan, Rui-Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6dfpj9jumugoljdo9s6ncjkmfp